• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmacogenomic testing: Enhancing personalized medication use for patients.药物基因组学检测：提升患者个性化用药水平。
Can Fam Physician. 2020 Apr;66(4):241-243.
2
Pharmacogenomics in the age of personalized medicine.个性化医疗时代的药物基因组学。
Drug Discov Today Technol. 2016 Sep-Dec;21-22:11-16. doi: 10.1016/j.ddtec.2016.11.003.
3
Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.利用临床数据存储库对药物基因组学指导的药物使用进行特征分析。
Clin Pharmacol Ther. 2017 Aug;102(2):340-348. doi: 10.1002/cpt.611. Epub 2017 Jun 5.
4
Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.个性化精准医学中的药物遗传学基础
Clin Lab Med. 2016 Sep;36(3):447-59. doi: 10.1016/j.cll.2016.05.006. Epub 2016 Jul 2.
5
Toward personalized medicine for intrahepatic cholangiocarcinoma: Pharmacogenomic stratification of patients.迈向肝内胆管癌的个性化医疗：患者的药物基因组分层
Hepatology. 2018 Sep;68(3):811-814. doi: 10.1002/hep.29830. Epub 2018 May 14.
6
The effects of sex on pharmacogenetically guided drug treatment.性别对药物基因组学指导下药物治疗的影响。
Pharmacogenomics. 2021 Oct;22(15):959-962. doi: 10.2217/pgs-2021-0088. Epub 2021 Sep 21.
7
Precision medicine: a call for increased pharmacogenomic education.精准医学：呼吁加强药物基因组学教育。
Per Med. 2019 May 1;16(3):233-245. doi: 10.2217/pme-2018-0107. Epub 2019 Apr 26.
8
The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.丹尼尔·K·伊努耶药学院文稿：通过药物基因组学实现精准医学：现状与实施障碍
Hawaii J Med Public Health. 2017 Sep;76(9):265-269.
9
Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).基于药物遗传学的个性化治疗：法国药物遗传学网络（RNPGx）的证据水平与建议
Therapie. 2017 Apr;72(2):185-192. doi: 10.1016/j.therap.2016.09.014. Epub 2017 Jan 30.
10
Pharmacogenomics and Personalized Medicine.药物基因组学与个性化医学。
Genes (Basel). 2020 Jun 22;11(6):679. doi: 10.3390/genes11060679.

引用本文的文献

1
Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application.抗抑郁药和抗精神病药的基因-药物配对：证据水平与临床应用
Mol Psychiatry. 2022 Jan;27(1):593-605. doi: 10.1038/s41380-021-01340-6. Epub 2021 Nov 9.

本文引用的文献

1
An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.对接受蒽环类药物治疗的儿童癌症患者进行药物基因组学检测的初步卫生经济学评价。
Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26887. Epub 2017 Dec 22.
2
Pharmacogenomics: Precision Medicine and Drug Response.药物基因组学：精准医学与药物反应。
Mayo Clin Proc. 2017 Nov;92(11):1711-1722. doi: 10.1016/j.mayocp.2017.09.001. Epub 2017 Nov 1.
3
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.关于基因检测以降低蒽环类药物所致心脏毒性发生率的建议。
Br J Clin Pharmacol. 2016 Sep;82(3):683-95. doi: 10.1111/bcp.13008. Epub 2016 Jun 30.
4
Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers.使用药物遗传学标志物管理和预防顺铂所致听力损失的临床实践建议
Ther Drug Monit. 2016 Aug;38(4):423-31. doi: 10.1097/FTD.0000000000000298.
5
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.RARG基因中的一个编码变异赋予儿童癌症患者对蒽环类药物诱导的心脏毒性的易感性。
Nat Genet. 2015 Sep;47(9):1079-84. doi: 10.1038/ng.3374. Epub 2015 Aug 3.
6
Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy.临床实践指南：用于安全有效可待因治疗的CYP2D6基因分型
J Popul Ther Clin Pharmacol. 2013;20(3):e369-96. Epub 2013 Nov 6.
7
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.TPMT 和 ABCC3 基因变异体的复制与儿童顺铂诱导性听力损失高度相关。
Clin Pharmacol Ther. 2013 Aug;94(2):243-51. doi: 10.1038/clpt.2013.80. Epub 2013 Apr 10.
8
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.验证 SLC28A3 和 UGT1A6 中的变体是否可作为预测儿童蒽环类药物诱导性心脏毒性的遗传标志物。
Pediatr Blood Cancer. 2013 Aug;60(8):1375-81. doi: 10.1002/pbc.24505. Epub 2013 Feb 25.
9
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.利用母亲遗传标志物的新组合预测婴儿及其母亲的可待因毒性。
Clin Pharmacol Ther. 2012 Apr;91(4):692-9. doi: 10.1038/clpt.2011.280. Epub 2012 Mar 7.
10
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.临床药物遗传学实施联盟（CPIC）关于细胞色素 P450 2D6（CYP2D6）基因型背景下的可待因治疗指南。
Clin Pharmacol Ther. 2012 Feb;91(2):321-6. doi: 10.1038/clpt.2011.287. Epub 2011 Dec 28.

Pharmacogenomic testing: Enhancing personalized medication use for patients.

作者信息

Loucks Catrina M, Groeneweg Gabriella, Roy Carl, Lee David K, Rieder Michael J, Lebel Denis, Ito Shinya, Ross Colin J, Carleton Bruce C

机构信息

Postdoctoral fellow in the Department of Pediatrics at the University of British Columbia in Vancouver.

Program Manager in the Department of Pediatrics at the University of British Columbia.

出版信息

Can Fam Physician. 2020 Apr;66(4):241-243.

PMID:32273406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7145138/
Abstract
摘要